Disease Progression:
Various factors
that influence HCV disease progression including steatosis, obesity, insulin
resistance, diabetes, race/ethnicity, and general studies on disease
progression.
·
General
o
62. Risk of Hepato-Pancreatico-Biliary Tumors Following Hepatitis C Virus
Infection: a Population-based Study on U.S. Veterans
o
280. The
Envelope Protein of the Hepatitis C virus (E2) inhibits IL-2 Secretion from T
lymphocytes
o
366. TLR-stimulated
non-parenchymal liver cells are potent suppressors of HCV replication.
o 438a. A comparison of risk
factors for intra- and extrahepatic cholangiocarcinoma in the United States: a
population-based case-control study.
o M1779. Hyperlipidemia is very
infrequent but is undertreated in chronic HCV. (updated,
May 21)
o M1783. Statins Improve ALT values
in Chronic Hepatitis C Patients with Abnormal Values. (updated, May 21)
o M1810. Serum Leptin
Concentrations In Chronic Viral Hepatitis: A Clinical Approach.
o M1820. Regulatory failure of
serum prohepcidin levels in patients with hepatitis C
o M1826. Hepatitis C and End Stage
Renal Disease: A Global Survey.
o M1829. Proteinuria in chronic
HCV infection: a link for chronic kidney disease (CKD)?
o M1836. Prevalence of Gallstones
Among Persons With Hepatitis C Virus Infection In Pakistan (updated,
May 23)
o M1837. Co-infection with
Cytomegalovirus in Chronic Hepatitis C Infection
o M.1839 Early Occult Portal
Hypertension in Chronic Hepatitis C (updated, May 28)
o S1055 Comorbid Medical and Psychiatric Illness and
Substance Abuse in HCV-Infected and Uninfected Veterans (updated, May 20)
·
Extrahepatic
Manifestations
o M1838. Clinical Spectrum of
Chronic Hepatitis C Virus-related Cryoglobulinemia in the US. (updated, May 21)
o M1843. Associations among Susceptibility Factors for Human
Porphyria Cutanea Tarda (updated, May 21)
o
M1853. Outcomes of pegylated interferon
and ribavirin therapy for HCV patients with cryoglobulinemia as compared to
patients without cryoglobulinemia.. (updated, May 21)
·
Metabolic disorders
o 513. Associate Factors Of
Nonalcoholic Fatty Liver Disease : Results From A Population-Based Study
o
M1819. The
association of selected adipokines with hepatic steatosis in patients with
chronic hepatitis C infection.
o
M1822. The association of
adipokine levels with changes in steatosis following treatment in patients with
chronic hepatitis C infection.
o
M1823. Chronic HCV Infection
causes Insulin Resistance- A Meta-analysis. (updated, May 23)
o M1831. Metabolic predictors of
steatosis and fibrosis in chronic hepatitis C(HCV). (updated,
May 21)
o
M1832. Lack of association
between hepatitis C and diabetes mellitus: a case-control study. (updated, May 23)
o T1072. Outcome of Japanese patients with cirrhosis due to
nonalcoholic steatohepatitis(NASH) and hepatitis C. (updated, May
22)
·
Race
o M1792. Clinical cirrhosis in
chronic hepatitis c (CHC) varies by race-ethnicity. (updated, May 22)